Neil has broad expertise in drug development, functional areas of business development, project management, regulatory affairs, and clinical project management and operations. As a Senior Director of External Innovation at Eli Lilly and Company, Neil was focused on venture capital backed investments into new company creation of project focused companies. Neil also held direct responsibilities for regulatory filings with major competent authorities globally, and for the design and oversight of early phase drug development programs, including phase 1 first-in-man clinical trials as part of Chorus, Eli Lilly’s virtual drug development engine. Prior to his current role at Censa, he was a Senior Director Project Management and Head BD with Flexion Therapeutics. Neil has a Doctor of Pharmacy degree from the University of Maryland Baltimore and a Master in Business Administration from the University of Baltimore.